Skip to content

Retrospective Survey for Patients With Hypertension and Diabetes Mellitus

A Retrospective, Multi Centre, Non-interventional, Observational Study to Investigate Treatment Pattern of Blood Pressure in the Type II Diabetes Mellitus Patients With Hypertension.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00681278
Acronym
CRYSTAL
Enrollment
2000
Registered
2008-05-21
Start date
2008-04-30
Completion date
2008-10-31
Last updated
2010-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Keywords

Hypertension, Type II DM, JNC7, 2007 ESH-ESC guidelines, survey

Brief summary

This study will address the treatment rate and control rate of hypertension, treatment pattern and factors to affect blood pressure control by examining (retrospective) medical records of hypertension patients having Type 2 Diabetes mellitus, among outpatients coming to the Endocrinology Department in 20 general hospital settings nationwide.

Interventions

None listed

Sponsors

AstraZeneca
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Outpatient Type II DM patients receiving hypertension medication in 2006 * Patient with Type II DM receiving hypertension medication during at least 1 year.

Exclusion criteria

* Secondary hypertension patients * Patients not receiving hypertension medication

Design outcomes

Primary

MeasureTime frame
Attainment rate to the target blood pressure.After collecting all Patient Record Form.

Secondary

MeasureTime frame
Dropout rate will be estimated during the follow-up period after the hypertension treatment. Attainment to the target blood pressure will be investigated according to concomitant diseases.After collecting all Patient Record Form.
Change in DBP/SBP value during the follow-up period will be addressed. Change in the DBP/SBP value will be investigated according to the risk factors and concurrent disease.After collecting all Patient Record Form.

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026